Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Net Income towards Common Stockholders (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of Net Income towards Common Stockholders data on record, last reported at -$689000.0 in Q4 2012.

  • For Q4 2012, Net Income towards Common Stockholders rose 72.95% year-over-year to -$689000.0; the TTM value through Mar 2013 reached -$2.1 million, up 71.87%, while the annual FY2012 figure was -$7.4 million, 3.69% up from the prior year.
  • Net Income towards Common Stockholders reached -$689000.0 in Q4 2012 per SNOA's latest filing, up from -$842000.0 in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$617000.0 in Q2 2012 and bottomed at -$2.5 million in Q4 2011.
  • Average Net Income towards Common Stockholders over 3 years is -$1.6 million, with a median of -$1.7 million recorded in 2010.
  • The widest YoY moves for Net Income towards Common Stockholders: up 72.95% in 2012, down 47.5% in 2012.
  • A 3-year view of Net Income towards Common Stockholders shows it stood at -$2.1 million in 2010, then decreased by 23.28% to -$2.5 million in 2011, then skyrocketed by 72.95% to -$689000.0 in 2012.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$689000.0 in Q4 2012, -$842000.0 in Q3 2012, and -$617000.0 in Q2 2012.